Jacobs & Co. CA Takes $10.36 Million Position in Intuitive Surgical, Inc. $ISRG

Jacobs & Co. CA acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 26,043 shares of the medical equipment provider’s stock, valued at approximately $10,356,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sax Wealth Advisors LLC boosted its position in Intuitive Surgical by 31.3% in the second quarter. Sax Wealth Advisors LLC now owns 3,316 shares of the medical equipment provider’s stock valued at $1,319,000 after buying an additional 791 shares during the last quarter. Hennion & Walsh Asset Management Inc. boosted its holdings in shares of Intuitive Surgical by 2.5% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 10,025 shares of the medical equipment provider’s stock valued at $3,987,000 after acquiring an additional 244 shares during the last quarter. Sunburst Financial Group LLC lifted its position in Intuitive Surgical by 5.7% during the second quarter. Sunburst Financial Group LLC now owns 574 shares of the medical equipment provider’s stock valued at $228,000 after purchasing an additional 31 shares during the period. Seilern Investment Management Ltd lifted its position in Intuitive Surgical by 17.6% during the second quarter. Seilern Investment Management Ltd now owns 115,695 shares of the medical equipment provider’s stock valued at $46,010,000 after purchasing an additional 17,337 shares during the period. Finally, Norway Savings Bank lifted its position in Intuitive Surgical by 2.5% during the second quarter. Norway Savings Bank now owns 3,253 shares of the medical equipment provider’s stock valued at $1,294,000 after purchasing an additional 78 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,634 shares of company stock valued at $2,796,795 in the last ninety days. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on ISRG shares. Bank of America cut their price target on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Raymond James Financial reissued an “outperform” rating and issued a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Leerink Partners lowered their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Finally, The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a research report on Wednesday, May 27th. Twenty research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $509.02.

Intuitive Surgical Stock Performance

ISRG opened at $378.81 on Friday. The company has a fifty day moving average of $392.87 and a two-hundred day moving average of $445.78. The stock has a market capitalization of $133.83 billion, a price-to-earnings ratio of 43.39, a PEG ratio of 2.74 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the company posted $1.81 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.